China Longevity Shares Remain Suspended on Hong Kong Stock Exchange Until Further NoticePUBT·Oct 30, 2026 at 08:41 AM018630.00%
China Longevity FY26 H1 profit attributable to owners climbs 22.7% to RMB 21.1 million; revenue rises 9.2% to RMB 646.1 millionPUBT·Aug 31, 2026 at 11:20 AM018630.00%
China Longevity Group shares stay suspended in Hong Kong since Feb. 2013PUBT·Jul 31, 2026 at 01:42 PM018630.00%
China Longevity Clarifies AGM Proxy Deadlines and Confirms No Final Dividend for 2025Tip Ranks·Apr 30, 2026 at 02:03 PM018630.00%
"Performance" CHI LONGEVITY Group's annual net profit is RMB 44.34 million, down 20.2%, no dividend declaredAASTOCKS·Mar 29, 2026 at 09:19 AM018630.00%
The Hong Kong Securities and Futures Commission seeks a court order to disqualify three former directors of CHI LONGEVITY Group LimitedZhitong·Oct 31, 2025 at 09:06 AM018630.00%
CHI LONGEVITY Group released its interim results, with a profit attributable to shareholders of HKD 17.211 million, a year-on-year decrease of 14.6%Zhitong·Aug 28, 2025 at 10:22 AM018630.00%
CHI LONGEVITY: Production, operations, and financial conditions remain stableZhitong·Aug 1, 2025 at 04:17 AM018630.00%
CHI LONGEVITY: The partial acquisition offer has become unconditional in all respectsZhitong·Apr 8, 2025 at 11:17 AM018630.00%
CHI LONGEVITY Group released its annual performance, with a profit attributable to shareholders of HKD 55.552 million, a year-on-year decrease of 11.82%Zhitong·Mar 28, 2025 at 10:11 AM018630.00%
CHI LONGEVITY establishes an independent director committee and continues to suspend tradingZhitong·Mar 3, 2025 at 08:42 AM018630.00%